Loading...

An investigation of the mechanisms underlying the proteasome inhibitor bortezomib resistance in PC3 prostate cancer cell line

The phenomenon of acquired resistance to chemotherapeutic agents is a long-standing conundrum in cancer treatment. To help delineate drug resistance mechanisms and pave the way for the development of novel strategies, we generated a PC3 prostate cancer cell line resistant to proteasome inhibitor bor...

Full description

Saved in:
Bibliographic Details
Published in:Cytotechnology
Main Authors: Yerlikaya, Azmi, Okur, Emrah
Format: Artigo
Language:Inglês
Published: Springer Netherlands 2019
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7002631/
https://ncbi.nlm.nih.gov/pubmed/31863311
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10616-019-00362-x
Tags: Add Tag
No Tags, Be the first to tag this record!